ANGPTL2 inhibits macrophage pyroptosis and alleviates rheumatoid arthritis progression by regulating mitophagy via IGFBP5
Authors:
Open Access
- 12 March 2026
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Abstract
Dysregulated macrophage pyroptosis and impaired mitophagy have emerged as critical drivers of rheumatoid arthritis (RA) progression, yet their upstream regulatory mechanisms remain unclear. Previous studies have demonstrated that ANGPTL2 deficiency aggravates alveolar bone loss in periodontitis, a condition that shares mechanistic similarities with RA in terms of bone destruction. Given the established link between periodontitis and RA, these findings suggest that ANGPTL2 may also play a protective role in RA-related joint pathology. In this study, we demonstrate that ANGPTL2 deficiency worsens joint inflammation, bone erosion, and macrophage pyroptosis in mice with collagen-induced arthritis (CIA). Mechanistically, ANGPTL2 loss impairs mitophagy and promotes mitochondrial dysfunction by inhibiting IGFBP5, leading to sustained NLRP3 inflammasome activation. Intra-articular administration of AAV- Angptl2 restores mitophagy, suppresses pyroptosis, and alleviates RA pathology. These findings identify ANGPTL2 as a key regulator of macrophage mitophagy and suggest its therapeutic potential in RA.Keywords
This publication has 91 references indexed in Scilit:
- VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathwayJournal of Gastroenterology, 2025
- Therapeutic Potential of Targeting the NLRP3 Inflammasome in Rheumatoid ArthritisInflammation, 2023
- Angiopoietin‐like protein 2 deficiency promotes periodontal inflammation and alveolar bone lossJournal of Periodontology, 2021
- The advances in pyroptosis initiated by inflammasome in inflammatory and immune diseasesInflammation Research, 2020
- Strategies toward rheumatoid arthritis therapy; the old and the newJournal of Cellular Physiology, 2018
- NLRP3: A promising therapeutic target for autoimmune diseasesAutoimmunity Reviews, 2018
- Association of Distinct Fine Specificities of Anti−Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and PeriodontitisArthritis & Rheumatology, 2017
- Differential Regulation of IL-1β and IL-6 Release in Murine MacrophagesInflammation, 2017
- ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patientsDiabetologia, 2016
- Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritisArthritis & Rheumatism, 2010